2seventy bio Inc (TSVT) Shares Down Despite Recent Market Volatility

The stock of 2seventy bio Inc (NASDAQ: TSVT) has decreased by -14.68 when compared to last closing price of 5.79.Despite this, the company has seen a gain of 0.82% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-04 that 2seventy bio (TSVT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is It Worth Investing in 2seventy bio Inc (NASDAQ: TSVT) Right Now?

Company’s 36-month beta value is 1.84.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for TSVT is 47.80M, and currently, short sellers hold a 10.99% ratio of that floaft. The average trading volume of TSVT on April 03, 2024 was 1.47M shares.

TSVT’s Market Performance

TSVT stock saw a decrease of 0.82% in the past week, with a monthly decline of -12.41% and a quarterly a decrease of 15.69%. The volatility ratio for the week is 12.08%, and the volatility levels for the last 30 days are 12.67% for 2seventy bio Inc (TSVT). The simple moving average for the past 20 days is 0.83% for TSVT’s stock, with a -3.30% simple moving average for the past 200 days.

Analysts’ Opinion of TSVT

Many brokerage firms have already submitted their reports for TSVT stocks, with Leerink Partners repeating the rating for TSVT by listing it as a “Outperform.” The predicted price for TSVT in the upcoming period, according to Leerink Partners is $18 based on the research report published on January 31, 2024 of the current year 2024.

Leerink Partners gave a rating of “Market Perform” to TSVT, setting the target price at $6 in the report published on October 30th of the previous year.

TSVT Trading at -0.18% from the 50-Day Moving Average

After a stumble in the market that brought TSVT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.07% of loss for the given period.

Volatility was left at 12.67%, however, over the last 30 days, the volatility rate increased by 12.08%, as shares sank -8.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +59.87% upper at present.

During the last 5 trading sessions, TSVT rose by +0.82%, which changed the moving average for the period of 200-days by -54.05% in comparison to the 20-day moving average, which settled at $4.88. In addition, 2seventy bio Inc saw 15.69% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TSVT starting from Casdin Capital, LLC, who purchase 40,000 shares at the price of $5.10 back on Mar 26 ’24. After this action, Casdin Capital, LLC now owns 2,000,000 shares of 2seventy bio Inc, valued at $203,992 using the latest closing price.

Casdin Capital, LLC, the Director of 2seventy bio Inc, purchase 330,000 shares at $5.07 during a trade that took place back on Mar 25 ’24, which means that Casdin Capital, LLC is holding 1,960,000 shares at $1,673,991 based on the most recent closing price.

Stock Fundamentals for TSVT

Current profitability levels for the company are sitting at:

  • -2.37 for the present operating margin
  • 0.8 for the gross margin

The net margin for 2seventy bio Inc stands at -2.12. The total capital return value is set at -0.47. Equity return is now at value -76.91, with -35.61 for asset returns.

Based on 2seventy bio Inc (TSVT), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at -0.65. The debt to equity ratio resting at 1.01. The interest coverage ratio of the stock is 51.41.

Currently, EBITDA for the company is -206.42 million with net debt to EBITDA at -0.98. When we switch over and look at the enterprise to sales, we see a ratio of 4.34. The receivables turnover for the company is 7.49for trailing twelve months and the total asset turnover is 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.98.

Conclusion

In a nutshell, 2seventy bio Inc (TSVT) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts